Core Structure of gp41 from the HIV Envelope Glycoprotein

Allan, 1990, Enhancement of SIV infection with soluble receptor molecules, Science, 247, 1084, 10.1126/science.2309120

Blacklow, 1995, A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein, Biochemistry, 34, 14955, 10.1021/bi00046a001

Broder, 1996, HIV and the 7-transmembrane domain receptors, Pathobiology, 64, 171, 10.1159/000164032

Brünger, A.T. (1992a). A system for X-ray crystallography and NMR. X-PLOR Version 3.1. (New Haven, Connecticut: Yale University Press).

Brünger, 1992, Free R value, Nature, 355, 472, 10.1038/355472a0

Bullough, 1994, Structure of influenza haemagglutinin at the pH of membrane fusion, Nature, 371, 37, 10.1038/371037a0

Cao, 1993, Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein, J. Virol., 67, 2747, 10.1128/jvi.67.5.2747-2755.1993

Carr, 1993, A spring-loaded mechanism for the conformational change of influenza hemagglutinin, Cell, 73, 823, 10.1016/0092-8674(93)90260-W

CCP4 (1994). Collaborative computational project, Number 4. Acta Cryst. D50, 760–763.

Chambers, 1990, Heptad repeat regions are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins, J. Gen. Virol., 71, 3075, 10.1099/0022-1317-71-12-3075

Chen, 1995, A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives, J. Virol., 69, 3771, 10.1128/jvi.69.6.3771-3777.1995

Chen, 1995, A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation, Proc. Natl. Acad. Sci. USA, 92, 12205, 10.1073/pnas.92.26.12205

Chen, 1994, Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41, J. Virol., 68, 2002, 10.1128/jvi.68.3.2002-2010.1994

Chen, 1993, Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein, J. Virol., 67, 3615, 10.1128/jvi.67.6.3615-3619.1993

Choe, 1996, The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates, Cell, 85, 1135, 10.1016/S0092-8674(00)81313-6

Cohen, 1990, Alpha-helical coiled coils and bundles, Proteins, 7, 1, 10.1002/prot.340070102

Cohen, 1996, Investigators detail HIV's fatal handshake, Science, 274, 502, 10.1126/science.274.5287.502

Cowtan, 1994, Joint CCP4 and ESF-EACBM, Newslett. Prot. Crystallogr., 31, 34

Crick, 1953, The packing of α-helices, Acta Cryst., 6, 689, 10.1107/S0365110X53001964

D'Souza, 1996, Chemokines and HIV-1 second receptors, Nature Med., 2, 1293, 10.1038/nm1296-1293

Daar, 1990, High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates, Proc. Natl. Acad. Sci. USA, 87, 6574, 10.1073/pnas.87.17.6574

Delwart, 1990, Retroviral envelope glycoproteins contain a leucine zipper-like repeat, AIDS Res. Hum. Retroviruses, 6, 703, 10.1089/aid.1990.6.703

Dubay, 1992, Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity, J. Virol., 66, 4748, 10.1128/jvi.66.8.4748-4756.1992

Edelhoch, 1967, Spectroscopic determination of tryptophan and tyrosine in proteins, Biochemistry, 6, 1948, 10.1021/bi00859a010

Fass, 1995, Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin, Curr. Biol., 5, 1377, 10.1016/S0960-9822(95)00275-2

Fass, 1996, Structure of Moloney murine virus envelope domain at 1.7Å resolution, Nature Struct. Biol., 3, 465, 10.1038/nsb0596-465

Freed, 1995, The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection, J. Biol. Chem., 270, 23883, 10.1074/jbc.270.41.23883

Gallaher, 1989, A general model for the transmembrane proteins of HIV and other retroviruses, AIDS Res. Hum. Retroviruses, 5, 431, 10.1089/aid.1989.5.431

Harbury, 1993, A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants, Science, 262, 1401, 10.1126/science.8248779

Harbury, 1994, Crystal structure of an isoleucine-zipper trimer, Nature, 371, 80, 10.1038/371080a0

Hart, 1991, Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120, Proc. Natl. Acad. Sci. USA, 88, 2189, 10.1073/pnas.88.6.2189

Helseth, 1991, Human immunodeficiency virus type 1 glycoprotein regions important for association with the gp41 transmembrane glycoprotein, J. Virol., 65, 2119, 10.1128/jvi.65.4.2119-2123.1991

Hendrickson, 1991, Determination of macromolecular structures from anomalous diffraction of synchrotron radiation, Science, 254, 51, 10.1126/science.1925561

Herskowitz, 1987, Functional inactivation of genes by dominant negative mutations, Nature, 329, 219, 10.1038/329219a0

Hunter, 1990, Retrovirus envelope glycoproteins, Curr. Top. Microbiol. Immunol., 157, 187

Jiang, 1993, HIV-1 inhibition by a peptide, Nature, 365, 113, 10.1038/365113a0

Jones, T.A., and Kjeldgaard, M. (1992). O—The Manual (Uppsala, Sweden: http://kaktus.kemi.aau.dk).

Kalyanaraman, 1990, Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1, AIDS Res. Hum. Retroviruses, 6, 371, 10.1089/aid.1990.6.371

Kraulis, 1991, MOLSCRIPT, J. Appl. Crystallogr., 24, 924, 10.1107/S0021889891004399

Lambert, 1996, Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion, Proc. Natl. Acad. Sci. USA, 93, 2186, 10.1073/pnas.93.5.2186

Laskowski, 1993, PROCHECK, J. Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944

Lawless, 1996, HIV-1 membrane fusion mechanism, Biochemistry, 35, 13697, 10.1021/bi9606962

Lipsky, 1996, Antiretroviral drugs for AIDS, Lancet, 348, 800, 10.1016/S0140-6736(95)12333-4

Lu, 1995, A trimeric structural domain of the HIV-1 transmembrane glycoprotein, Nature Struct. Biol., 2, 1075, 10.1038/nsb1295-1075

Luciw, P.A. (1996). Human immunodeficiency viruses and their replication. In Fields Virology, Third Edition, B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.E. Straus, eds. (Philadelphia: Lippincott-Raven Publishers), pp. 1881–1952.

Moore, 1990, Dissociation of gp120 from HIV-1 virions induced by soluble CD4, Science, 250, 1139, 10.1126/science.2251501

Moore, 1995, Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120, J. Virol., 69, 101, 10.1128/jvi.69.1.101-109.1995

Nara, 1988, Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies, J. Virol., 62, 2622, 10.1128/jvi.62.8.2622-2628.1988

Nicholls, 1991, Protein folding and association, Proteins, 11, 281, 10.1002/prot.340110407

Oas, 1988, A peptide model of a protein folding intermediate, Nature, 336, 42, 10.1038/336042a0

O'Shea, 1991, X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil, Science, 254, 539, 10.1126/science.1948029

Otwinoski, Z. (1991). Maximum likelihood refinement of heavy atom parameters. In Isomorphous Replacement and Anomalous Scattering. W. Wolf, P.R. Evans, and A.G.W. Leslie, eds. (Warrington, England: SERC, Daresbury Laboratory) pp. 80–86.

Otwinoski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing. L. Sawyer, N. Isaacs, S. Bailey, eds. (Warrington, England: SERC, Daresbury Laboratory) pp. 56–62.

Palker, 1988, Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides, Proc. Natl. Acad. Sci. USA, 85, 1932, 10.1073/pnas.85.6.1932

Poumbourios, 1997, Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence, J. Virol., 71, 2041, 10.1128/jvi.71.3.2041-2049.1997

Rabenstein, 1996, HIV-1 gp41 tertiary structure studied by EPR spectroscopy, Biochemistry, 35, 13922, 10.1021/bi961743t

Rabenstein, 1995, A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation, Biochemistry, 34, 13390, 10.1021/bi00041a016

Sattentau, 1991, Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding, J. Exp. Med., 174, 407, 10.1084/jem.174.2.407

Sattentau, 1993, The role of CD4 in HIV binding and entry, Phil. Trans. Royal Soc. B, 342, 59, 10.1098/rstb.1993.0136

Sattentau, 1993, Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding, J. Virol., 67, 7383, 10.1128/jvi.67.12.7383-7393.1993

Shugars, 1996, Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41, J. Virol., 70, 2982, 10.1128/jvi.70.5.2982-2991.1996

Stamatatos, 1995, Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding, J. Virol., 69, 6191, 10.1128/jvi.69.10.6191-6198.1995

Stegmann, 1991, The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion, J. Biol. Chem., 266, 18404, 10.1016/S0021-9258(18)55284-4

Stegmann, T., and Helenius, A. (1993). Influenza virus fusion: from models toward a mechanism. In Viral Fusion Mechanisms, J. Bentz, ed. (Boca Raton, Florida: CRC Press), pp. 89–111.

Sullivan, 1995, Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates, J. Virol., 69, 4413, 10.1128/jvi.69.7.4413-4422.1995

Trkola, 1996, CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5, Nature, 384, 184, 10.1038/384184a0

Tsurudome, 1992, Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion, J. Biol. Chem., 267, 20225, 10.1016/S0021-9258(19)88690-8

White, 1992, Membrane fusion, Science, 258, 917, 10.1126/science.1439803

Wild, 1992, A synthetic peptide inhibitor of human immunodeficiency virus replication, Proc. Natl. Acad. Sci. USA, 89, 10537, 10.1073/pnas.89.21.10537

Wild, 1994, Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex, Proc. Natl. Acad. Sci. USA, 91, 12676, 10.1073/pnas.91.26.12676

Wild, 1994, Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection, Proc. Natl. Acad. Sci. USA, 91, 9770, 10.1073/pnas.91.21.9770

Wild, 1995, The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure, AIDS Res. Hum. Retroviruses, 11, 323, 10.1089/aid.1995.11.323

Wiley, 1987, The structure and function of the hemagglutinin membrane glycoprotein of influenza virus, Annu. Rev. Biochem., 56, 365, 10.1146/annurev.bi.56.070187.002053

Wilkinson, 1996, HIV-1, Curr. Biol., 6, 1051, 10.1016/S0960-9822(02)70661-1

Wilson, 1981, Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution, Nature, 289, 366, 10.1038/289366a0

Wu, 1996, CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5, Nature, 384, 179, 10.1038/384179a0